We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!

MSFT 409.6999 -1.5286% AAPL 222.71 -1.8034% NVDA 128.3057 2.7103% GOOGL 163.14 -2.3465% GOOG 164.6592 -2.3142% AMZN 180.47 -3.2384% META 585.16 -1.8089% AVGO 175.79 -0.4812% TSLA 241.6955 -3.3527% TSM 183.57 1.3303% LLY 899.35 1.374% V 273.29 -1.6695% JPM 209.74 -0.7007% UNH 584.575 -1.1206% NVO 117.48 2.05% WMT 79.45 -1.8409% LVMUY 148.82 1.4451% XOM 125.47 0.5127% LVMHF 745.0 1.5609% MA 491.24 -1.298%

Safeguard Scientifics Inc. Common Stock

Financial Services US SFE

0.775USD
0.32(70.33%)

Last update at 2024-03-06T14:30:00Z

Day Range

0.750.78
LowHigh

52 Week Range

0.622.12
LowHigh

Fundamentals

  • Previous Close 0.46
  • Market Cap16.74M
  • Volume2422
  • P/E Ratio-
  • Dividend Yield2.10%
  • EBITDA-7.35800M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.63

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -14.26300M 27.00M -37.61500M 54.56M -15.62900M
Minority interest - - - - -
Net income -23.75100M 46.43M -34.06900M 41.76M -15.62900M
Selling general administrative 4.62M 7.15M 6.18M 8.36M 16.87M
Selling and marketing expenses - - - - -
Gross profit -3.29700M 22.04M -7.70800M 12.26M 0.00000M
Reconciled depreciation 0.27M 0.23M 0.31M 1.07M 0.69M
Ebit -4.77500M -7.15300M -9.46600M -9.98200M 0.44M
Ebitda -4.45900M -26.07000M -2.89600M -7.53600M 1.13M
Depreciation and amortization 0.32M -18.91700M 6.57M 2.45M 0.69M
Non operating income net other - - -28.14900M 78.57M 17.31M
Operating income -4.77500M -7.15300M -9.46600M -9.98200M -16.87100M
Other operating expenses 4.62M 7.15M 6.18M 9.16M 16.87M
Interest expense 0.04M 34.16M 0.00000M 14.02M 16.07M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.79M 12.12M 9.16M 2.04M 2.81M
Net interest income 0.79M 0.28M 0.26M -11.97900M -13.26100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 9.49M -19.42200M -3.54600M 12.80M 17.31M
Total revenue -3.29700M 22.04M -7.70800M 12.26M 0.00000M
Total operating expenses 4.62M 7.15M 6.18M 9.16M 16.87M
Cost of revenue - - - - 0.00000M
Total other income expense net -9.48800M 34.16M -28.14900M 64.54M 14.50M
Discontinued operations - - - - -
Net income from continuing ops -14.26300M 27.00M -37.61500M 54.56M -15.62900M
Net income applicable to common shares -14.26300M 27.00M -37.61500M 54.56M -15.62900M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 37.69M 54.03M 69.03M 107.58M 145.74M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 1.25M 0.96M 0.46M 1.30M 2.67M
Total liab 3.12M 3.46M 6.16M 5.84M 78.76M
Total stockholder equity 34.58M 50.57M 62.88M 101.74M 66.98M
Deferred long term liab - - - - -
Other current liab 1.37M 1.73M 3.47M 2.43M 5.06M
Common stock 2.16M 2.16M 2.16M 2.16M 2.16M
Capital stock 2.16M 2.16M 2.16M 2.16M 2.16M
Retained earnings -723.89800M -709.63500M -736.63900M -697.22300M -731.10500M
Other liab 0.05M 0.05M 0.64M 1.03M 2.80M
Good will - - - - -
Other assets 4.82M 54.03M 51.18M 17.10M 17.93M
Cash 19.31M 24.74M 15.60M 25.03M 7.70M
Cash and equivalents - 24.74M 15.60M 25.03M 7.70M
Total current liabilities 1.82M 1.73M 3.47M 2.43M 32.94M
Current deferred revenue - -0.41600M -0.38300M -0.43800M 0.56M
Net debt -17.63400M -22.68600M -13.54800M -22.64800M 62.47M
Short term debt 0.43M 0.38M 0.33M 0.40M 27.16M
Short long term debt - - - - 27.16M
Short long term debt total 1.68M 2.05M 2.05M 2.38M 70.17M
Other stockholder equity 756.34M 758.07M 797.38M 796.83M 795.93M
Property plant equipment 1.29M 1.56M 1.79M 2.10M 0.81M
Total current assets 21.42M 30.28M 16.06M 26.35M 48.83M
Long term investments 14.54M 21.97M 50.40M 77.13M 95.58M
Net tangible assets 34.58M 50.57M 62.88M 101.74M 66.98M
Short term investments 0.86M 4.55M - 0.03M 37.95M
Net receivables - - 0.78M - -
Long term debt - - - 0.00000M 43.01M
Inventory - - - - -
Accounts payable 0.02M 0.04M 0.06M 0.04M 0.17M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.02500M -0.02500M -0.02500M -0.02500M -
Additional paid in capital - - - - -
Common stock total equity - - 2.16M 2.16M 2.16M
Preferred stock total equity - - - - -
Retained earnings total equity - - -736.63900M -697.22300M -731.10500M
Treasury stock - -48.56900M -10.20000M -14.02400M -15.00100M
Accumulated amortization - - - - -
Non currrent assets other 0.43M 0.22M 0.78M 2.00M 0.52M
Deferred long term asset charges - - - - -
Non current assets total 16.27M 23.75M 52.97M 81.23M 96.91M
Capital lease obligations 1.25M 2.05M 2.05M 2.78M -
Long term debt total - 0.00000M 0.00000M 0.00000M 43.01M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -4.66200M 60.83M -9.17200M 22.00M -35.28500M
Change to liabilities -0.37400M -3.04500M -0.07700M -3.34600M -0.02100M
Total cashflows from investing activities -4.66200M 58.11M -1.26900M 126.30M 32.10M
Net borrowings - - - -68.56800M -24.68500M
Total cash from financing activities -3.48800M -40.79900M -0.04000M -89.48300M -24.95200M
Change to operating activities -0.53400M -0.23800M -0.13700M -0.82300M -2.06500M
Net income -14.26300M 27.00M -37.61500M 54.56M -15.62900M
Change in cash -11.40800M 9.16M -9.45200M 16.85M -18.88400M
Begin period cash flow 24.76M 15.60M 25.05M 8.20M 27.09M
End period cash flow 13.36M 24.76M 15.60M 25.05M 8.20M
Total cash from operating activities -3.25800M -8.15200M -8.14300M -19.97000M -26.03500M
Issuance of capital stock - - - - -
Depreciation 0.27M 0.23M 0.31M 1.07M 0.69M
Other cashflows from investing activities -5.67000M -2.71800M 7.90M 104.30M 67.39M
Dividends paid - - 0.00000M -20.67900M -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock -2.93900M -40.65500M - - 0.00000M
Other cashflows from financing activities -0.54900M -0.14400M -0.04000M -0.23600M 32.48M
Change to netincome 11.64M -32.10200M 21.00M -68.09000M -14.14200M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00100M
Change receivables - - - -0.82300M -2.06500M
Cash flows other operating - - 8.54M -6.53400M 0.62M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -9.45200M 16.85M -18.88400M
Change in working capital -0.90800M -3.28300M -0.21400M -4.16900M -2.08600M
Stock based compensation 1.45M 1.78M 0.96M 1.24M 0.97M
Other non cash items 10.20M -0.02200M 0.17M 1.19M 6.54M
Free cash flow -3.25800M -8.15200M -8.14300M -19.97000M -26.03400M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
SFE
Safeguard Scientifics Inc. Common Stock
0.32 70.33% 0.78 - - - 0.55 -0.4826
BX
Blackstone Group Inc
-3.28 2.16% 148.64 54.68 21.93 18.77 13.26 8.40
BLK
BlackRock Inc
-11.23 1.18% 937.96 34.48 22.47 6.68 3.04 6.82 15.82
KKR
KKR & Co LP
-1.8924 1.43% 130.28 29.90 16.84 4.76 3.56 2.50 4.66
IVSBF
Investor AB ser. B
- -% 30.25 6.10 - 0.41 1.04 0.24 1.68

Reports Covered

Stock Research & News

Profile

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Sa

Safeguard Scientifics Inc. Common Stock

150 North Radnor Chester Road, Radnor, PA, United States, 19087

Key Executives

Name Title Year Born
Mr. Eric C. Salzman Chief Exec. Officer 1967
Mr. Mark A. Herndon CPA Sr. VP & CFO 1970
Mr. G. Matthew Barnard Gen. Counsel, Sec. & Compliance Officer NA
Ms. Alex A. Fuiks Associate NA
Mr. Seth Zuckerman Sr. Associate of Healthcare NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.